FTC cracks down on DaVita's market power

  • 📰 axios
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 63%

इंडिया समाचार समाचार

इंडिया ताज़ा खबर,इंडिया मुख्य बातें

The Federal Trade Commission has the dialysis industry in its crosshairs after it finalized restrictions on DaVita's latest deal in Utah.

agreement

allows DaVita to purchase 18 dialysis clinics owned by University of Utah Health, but three acquired clinics in the Provo, Utah area must be divested. DaVita also can't buy another clinic in Utah for 10 years unless it gets prior FTC approval, nor can it prevent employees at the acquired clinics from jumping to jobs at competing dialysis clinics.

If the FTC didn't impose these conditions, DaVita would have owned seven of the eight dialysis clinics in the Provo area.

 

आपकी टिप्पणी के लिए धन्यवाद। आपकी टिप्पणी समीक्षा के बाद प्रकाशित की जाएगी।
हमने इस समाचार को संक्षेप में प्रस्तुत किया है ताकि आप इसे तुरंत पढ़ सकें। यदि आप समाचार में रुचि रखते हैं, तो आप पूरा पाठ यहां पढ़ सकते हैं। और पढो:

 /  🏆 302. in İN

इंडिया ताज़ा खबर, इंडिया मुख्य बातें